Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 448
Selected: 0
NCT IDTitle
NCT00281736Photodynamic Therapy in Treating Patients With Precancerous Esophageal Conditions or Early Stage Esophageal Cancer
NCT00536601High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
NCT04876248Belantamab Mafodotin and Lenalidomide for the Treatment of Multiple Myeloma in Patients With Minimal Residual Disease Positive After Stem Cell Transplant
NCT00022035Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia
NCT04682158Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
NCT00002945High Dose Chemotherapy, Peripheral Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Acute Myeloid Leukemia
NCT07039630A Food Security Intervention for the Prevention of Cancer in Low-income Families
NCT03685695Physical Activity Monitored by Fitbit Charge 2 in Improving Quality of Life in Participants With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT04097028Use of Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy for the Treatment of Resectable Esophageal or Gastroesophageal Junction (GEJ) Adenocarcinoma
NCT07489287GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer
NCT00470184Oxaliplatin, Capecitabine, and Radiation Therapy in Patients Undergoing Surgery for Stage II, III, IV Esophageal Cancer
NCT01959698Carfilzomib, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Relapsed or Refractory Stage I-IV Diffuse Large B-cell Lymphoma
NCT01027416Analyzing a New Mechanism in Response to Tamoxifen Therapy in Breast Cancer Patients
NCT06733350Testosterone Replacement Therapy for the Treatment of Low Testosterone in Hypogonadal Men With Localized Prostate Cancer on Active Surveillance
NCT02947386Nimotuzumab and Nivolumab in Treating Patients With Advanced Non-small Cell Lung Cancer
NCT05587582Behavioral Parenting Skills As A Novel Target for Improving Pediatric Medication Adherence
NCT04635761Awareness, Information, and Resources for Lung Cancer Screening Program for Community-Partnered Lung Cancer Screening
NCT01564277Rasburicase and Allopurinol in Treating Patients With Hematologic Malignancies
NCT00646139KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment
NCT07158749Generalized and Domain-Specific Episodic Thinking for Smoking Cessation
NCT04297384Breast Cancer Pathways Program Impact on Patient Shared Decision Making and Experience in Academic and Community Practice
NCT01198548High-Dose Cholecalciferol in Treating Patients Receiving Combination Chemotherapy and Bevacizumab as First-Line Therapy For Metastatic Colorectal Cancer
NCT02531906Gabapentin, Methadone Hydrochloride, and Oxycodone Hydrochloride in Improving Quality of Life in Patients With Stage II-IV Head and Neck Cancer During Chemoradiation
NCT01007552A Study of Gemcitabine, Capecitabine and Bevacizumab to Treat Cancer of the Gall Bladder or Bile Ducts
NCT06758011ivWatch in Prevention of Extravasation of Vesicants in an Oncology Setting
NCT01800500Interest in Smokeless Tobacco Product as a Substitution for Cigarettes in Current Smokers
NCT03589456Establishment of a PDT Patient Registry
NCT02068157Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer
NCT02713373Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery
NCT06055231PK/PD of Vaping THC-containing Liquids vs. Smoked Cannabis
NCT06563388Stereotactic Ablative Radiotherapy (SABR) for the Treatment of Patients With Metastatic Cancer, ID-COMET Trial
NCT01032148Study of LBH589, A Deacetylase Inhibitor in Patients With Recurrent or Refractory Hodgkin or Non-Hodgkin's Lymphoma
NCT06821997NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial
NCT00803569Vaccine Therapy in Stage II, III, or IV Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancers
NCT02100254Narrative or Fact-Based Videos in Increasing Colorectal Cancer Screenings in African American Communities
NCT05338905Intensive Symptom Surveillance Guided by Machine Learning-Directed Risk Stratification in Patients With Non-Metastatic Head and Neck Cancer, The INSIGHT Trial
NCT02334865SVN53-67/M57-KLH Peptide Vaccine in Treating Patients With Newly Diagnosed Multiple Myeloma Receiving Lenalidomide Maintenance Therapy
NCT01545141Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer
NCT00024141Irinotecan Followed by Fluorouracil in Treating Patients With Advanced Solid Tumors
NCT05098002Mindfulness Meditation
NCT05764330Weight Loss Interventions to Reduce Cancer Progression in Prostate Cancer Patients Under Active Surveillance
NCT02119728Photodynamic Therapy With HPPH in Treating Patients With Squamous Cell Carcinoma of the Oral Cavity
NCT01522820Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
NCT06670976Propranolol Plus Standard Radiation Therapy Before Surgery for the Treatment of Patients With Soft Tissue Sarcoma
NCT00002578Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
NCT04802447SurVaxM Expanded Access Protocol
NCT02452463Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy
NCT01744171Vaccine Therapy in Treating Patients With Advanced Stage III-IV Melanoma
NCT01982487Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in Remission
NCT01004159Cetuximab Plus Irinotecan in Colorectal Cancer Patients Who Progressed After Failure With Cetuximab Plus Irinotecan